Cytokine profiling identifies an interaction of IL-6 and IL- to drive PSMA-PSA prostate clones
详细信息    查看全文
文摘
Several PSMA-PSA prostate clones have been identified during prostate cancer progression; however, until now, their in situ inflammatory characteristics have remained unclear.

Aim

We therefore investigated the interplay between proinflammatory cytokines and (PSMA,PSA) sub-groups.

Materials and methods

27 benign prostate hyperplasia (BPH) and 18 prostate cancers (PC) were enrolled in this study. Immunohistochemical analysis was performed. Serum levels of PSA were assayed by Immulite autoanalyser.

Results

In BPH and PC patients with elevated serum PSA levels, IL- was the most proinflammatory cytokine expressed in (PSMA+,PSA−) subgroup. However, most samples of (PSMA+,PSA+) subgroup had positive immunoreaction to IL-6. In samples of PC with PSA serum levels of 4–20 ng/mL or >20 ng/mL, immunoreaction to TNF-α was seen only in (PSMA+,PSA+) subgroup. Interestingly, several combinations of proinflammatory cytokines (IL-6, IL- and TNF-α) showed that coexpression of tissue PSMA and PSA was concomitant with high immunoreactions to (IL-6+,TNF-α-), (IL-6+,IL-+) and (IL-+,TNFα−) in BPH and PC patients. (PSMA,PSA) subgroup lacking tissue PSA expression showed a high immunoexpression of the profile (IL-6+,TNF-α-). The combinations of (IL-6-, TNF-α-) and (IL-6-, IL--) were absent in (PSMA+,PSA−) and (PSMA+,PSA+) BPH sub-groups.

Conclusion

Collectively, these findings underscore the importance of TNF-α and highlight the interaction between IL-6 and IL- to generate an inflammatory microenvironment in driving (PSMA,PSA) prostate clones.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700